| 000 | 01483 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518054558.0 | ||
| 264 | 0 | _c20200622 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1651-226X | ||
| 024 | 7 |
_a10.1080/0284186X.2019.1652765 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFosså, Alexander | |
| 245 | 0 | 0 |
_aBrentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _cJan 2020 |
||
| 300 |
_a101-105 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAllografts |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
| 650 | 0 | 4 |
_aBrentuximab Vedotin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNorway |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSmeland, Knut | |
| 700 | 1 | _aFagerli, Unn-Merete | |
| 700 | 1 | _aGalleberg, Renate B | |
| 700 | 1 | _aBersvendsen, Hanne S | |
| 700 | 1 | _aHolte, Harald | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 59 _gno. 1 _gp. 101-105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/0284186X.2019.1652765 _zAvailable from publisher's website |
| 999 |
_c30021891 _d30021891 |
||